Healthcare News

Browse the latest Healthcare news, including Healthcare Providers, Medical Equipment, Medical Supplies and Services, Biotechnology and Pharmaceuticals, and Cannabis industries. Use the menu or navigation tiles to get to specific industries within each sector.

January 23, 2026 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at ASTS
January 23, 2026 06:00 ET | Source: Coloplast Finance B.V.

Coloplast Finance B.V. - Decisions at the Annual General Meeting

On 23 January 2026, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder, Coloplast A/S, approved the annual report for the financial year...
January 23, 2026 02:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic indgår distributionsaftale med Eurofarma for at udvide adgangen til chikungunya-vacciner i Brasilien

Aftalen muliggør den første markedslancering i Latinamerika for Bavarian Nordics chikungunya‑vaccineRummer mulighed for udvidelse til at dække resten af Latinamerika KØBENHAVN, Danmark, 23. januar...
January 23, 2026 02:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil

Bavarian Nordic has signed a distribution agreement with Eurofarma for its chikungunya vaccine in Brazil with potential to expand to rest of Latin America
January 23, 2026 01:30 ET | Source: ONWARD Medical NV

ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer

EINDHOVEN, the Netherlands, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to...
January 23, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique

L’amlitelimab de Sanofi confirme son potentiel dans la dermatite atopique Dans l'étude de phase 3 SHORE, l'amlitelimab en association avec des traitements topiques a atteint tous les critères...
January 23, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis

Sanofi's amlitelimab confirms its potential in atopic dermatitis In the SHORE phase 3 study, amlitelimab in combination with topical therapies met all primary and key secondary endpoints at Week 24...
January 22, 2026 17:00 ET | Source: Vaxcyte, Inc.

Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine

VAX-31 Adult Indication: Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza Vaccine (OPUS-2) and Expects to Initiate Phase 3 Study...
January 22, 2026 16:05 ET | Source: Intuitive Surgical, Inc.

Intuitive Announces Fourth Quarter Earnings

SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery,...
January 22, 2026 16:05 ET | Source: Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic...